Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 45

1.

Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: implications for pandemrix-associated narcolepsy risk.

Vaarala O, Vuorela A, Partinen M, Baumann M, Freitag TL, Meri S, Saavalainen P, Jauhiainen M, Soliymani R, Kirjavainen T, Olsen P, Saarenpää-Heikkilä O, Rouvinen J, Roivainen M, Nohynek H, Jokinen J, Julkunen I, Kilpi T.

PLoS One. 2014 Dec 15;9(12):e114361. doi: 10.1371/journal.pone.0114361. eCollection 2014.

2.

Altered duodenal microbiota composition in celiac disease patients suffering from persistent symptoms on a long-term gluten-free diet.

Wacklin P, Laurikka P, Lindfors K, Collin P, Salmi T, Lähdeaho ML, Saavalainen P, Mäki M, Mättö J, Kurppa K, Kaukinen K.

Am J Gastroenterol. 2014 Dec;109(12):1933-41. doi: 10.1038/ajg.2014.355. Epub 2014 Nov 18.

PMID:
25403367
3.

Impaired epithelial integrity in the duodenal mucosa in early stages of celiac disease.

Rauhavirta T, Lindfors K, Koskinen O, Laurila K, Kurppa K, Saavalainen P, Mäki M, Collin P, Kaukinen K.

Transl Res. 2014 Sep;164(3):223-31. doi: 10.1016/j.trsl.2014.02.006. Epub 2014 Jun 18.

PMID:
25005738
4.

Benefits of a gluten-free diet for asymptomatic patients with serologic markers of celiac disease.

Kurppa K, Paavola A, Collin P, Sievänen H, Laurila K, Huhtala H, Saavalainen P, Mäki M, Kaukinen K.

Gastroenterology. 2014 Sep;147(3):610-617.e1. doi: 10.1053/j.gastro.2014.05.003. Epub 2014 May 13.

PMID:
24837306
5.

Testing safety of germinated rye sourdough in a celiac disease model based on the adoptive transfer of prolamin-primed memory T cells into lymphopenic mice.

Freitag TL, Loponen J, Messing M, Zevallos V, Andersson LC, Sontag-Strohm T, Saavalainen P, Schuppan D, Salovaara H, Meri S.

Am J Physiol Gastrointest Liver Physiol. 2014 Mar;306(6):G526-34. doi: 10.1152/ajpgi.00136.2013. Epub 2014 Jan 23.

6.

Gene Expression Profiling of Gliadin Effects on Intestinal Epithelial Cells Suggests Novel Non-Enzymatic Functions of Pepsin and Trypsin.

Parmar A, Greco D, Venäläinen J, Gentile M, Dukes E, Saavalainen P.

PLoS One. 2013 Jun 18;8(6):e66307. Print 2013.

7.

Aging bone marrow mesenchymal stromal cells have altered membrane glycerophospholipid composition and functionality.

Kilpinen L, Tigistu-Sahle F, Oja S, Greco D, Parmar A, Saavalainen P, Nikkilä J, Korhonen M, Lehenkari P, Käkelä R, Laitinen S.

J Lipid Res. 2013 Mar;54(3):622-35. doi: 10.1194/jlr.M030650. Epub 2012 Dec 27.

8.

Association study of FUT2 (rs601338) with celiac disease and inflammatory bowel disease in the Finnish population.

Parmar AS, Alakulppi N, Paavola-Sakki P, Kurppa K, Halme L, Färkkilä M, Turunen U, Lappalainen M, Kontula K, Kaukinen K, Mäki M, Lindfors K, Partanen J, Sistonen P, Mättö J, Wacklin P, Saavalainen P, Einarsdottir E.

Tissue Antigens. 2012 Dec;80(6):488-93. doi: 10.1111/tan.12016. Epub 2012 Oct 18.

PMID:
23075394
9.

Degree of damage to the small bowel and serum antibody titers correlate with clinical presentation of patients with celiac disease.

Taavela J, Kurppa K, Collin P, Lähdeaho ML, Salmi T, Saavalainen P, Haimila K, Huhtala H, Laurila K, Sievänen H, Mäki M, Kaukinen K.

Clin Gastroenterol Hepatol. 2013 Feb;11(2):166-71.e1. doi: 10.1016/j.cgh.2012.09.030. Epub 2012 Oct 9.

PMID:
23063678
10.

Methods for diagnostic HLA typing in disease association and drug hypersensitivity.

Varney MD, Castley AS, Haimila K, Saavalainen P.

Methods Mol Biol. 2012;882:27-46. doi: 10.1007/978-1-61779-842-9_3.

PMID:
22665227
11.

Endomysial antibodies predict celiac disease irrespective of the titers or clinical presentation.

Kurppa K, Räsänen T, Collin P, Iltanen S, Huhtala H, Ashorn M, Saavalainen P, Haimila K, Partanen J, Mäki M, Kaukinen K.

World J Gastroenterol. 2012 May 28;18(20):2511-6. doi: 10.3748/wjg.v18.i20.2511.

12.

Association of celiac disease genes with inflammatory bowel disease in Finnish and Swedish patients.

Parmar AS, Lappalainen M, Paavola-Sakki P, Halme L, Färkkilä M, Turunen U, Kontula K, Aromaa A, Salomaa V, Peltonen L, Halfvarson J, Törkvist L, D'Amato M, Saavalainen P, Einarsdottir E.

Genes Immun. 2012 Sep;13(6):474-80. doi: 10.1038/gene.2012.21. Epub 2012 May 17.

PMID:
22592522
13.

Utility of the new ESPGHAN criteria for the diagnosis of celiac disease in at-risk groups.

Kurppa K, Salminiemi J, Ukkola A, Saavalainen P, Löytynoja K, Laurila K, Collin P, Mäki M, Kaukinen K.

J Pediatr Gastroenterol Nutr. 2012 Mar;54(3):387-91. doi: 10.1097/MPG.0b013e3182407c6b.

PMID:
22094901
14.

Genome-wide analysis of extended pedigrees confirms IL2-IL21 linkage and shows additional regions of interest potentially influencing coeliac disease risk.

Einarsdottir E, Koskinen LL, de Kauwe AL, Dukes E, Mustalahti K, Balogh M, Korponay-Szabo IR, Kaukinen K, Kurppa K, Adány R, Pocsai Z, Széles G, Mäki M, Kere J, Saavalainen P.

Tissue Antigens. 2011 Dec;78(6):428-37. doi: 10.1111/j.1399-0039.2011.01791.x.

PMID:
22077623
15.

Gluten-sensitive hypertransaminasemia in celiac disease: an infrequent and often subclinical finding.

Korpimäki S, Kaukinen K, Collin P, Haapala AM, Holm P, Laurila K, Kurppa K, Saavalainen P, Haimila K, Partanen J, Mäki M, Lähdeaho ML.

Am J Gastroenterol. 2011 Sep;106(9):1689-96. doi: 10.1038/ajg.2011.134. Epub 2011 Apr 19.

PMID:
21502996
16.

IgA-class autoantibodies against neuronal transglutaminase, TG6 in celiac disease: no evidence for gluten dependency.

Lindfors K, Koskinen O, Laurila K, Collin P, Saavalainen P, Haimila K, Partanen J, Mäki M, Kaukinen K.

Clin Chim Acta. 2011 Jun 11;412(13-14):1187-90. doi: 10.1016/j.cca.2010.09.042. Epub 2011 Mar 29.

PMID:
21453693
17.

Serodiagnostic assays for celiac disease based on the open or closed conformation of the autoantigen, transglutaminase 2.

Lindfors K, Koskinen O, Kurppa K, Laurila K, Collin P, Haimila K, Partanen J, Saavalainen P, Mäki M, Kaukinen K.

J Clin Immunol. 2011 Jun;31(3):436-42. doi: 10.1007/s10875-011-9514-x. Epub 2011 Mar 9.

PMID:
21384250
18.

Functional polymorphism in IL12B promoter site is associated with ulcerative colitis.

Szperl A, Saavalainen P, Weersma RK, Lappalainen M, Paavola-Sakki P, Halme L, Färkkilä M, Turunen U, Kontula K, Ponsioen CY, Wijmenga C, van Diemen CC.

Inflamm Bowel Dis. 2011 Jun;17(6):E38-40. doi: 10.1002/ibd.21670. Epub 2011 Feb 23. No abstract available.

PMID:
21351215
19.

Multiple independent variants in 6q21-22 associated with susceptibility to celiac disease in the Dutch, Finnish and Hungarian populations.

Einarsdottir E, Bevova MR, Zhernakova A, Monsuur A, Koskinen LL, van't Slot R, Mulder C, Mearin ML, Korponay-Szabo IR, Kaukinen K, Kurppa K, Kere J, Mäki M, Wijmenga C, Saavalainen P.

Eur J Hum Genet. 2011 Jun;19(6):682-6. doi: 10.1038/ejhg.2011.2. Epub 2011 Feb 16.

20.

Antibodies against deamidated gliadin peptides in early-stage celiac disease.

Kurppa K, Lindfors K, Collin P, Saavalainen P, Partanen J, Haimila K, Huhtala H, Laurila K, Mäki M, Kaukinen K.

J Clin Gastroenterol. 2011 Sep;45(8):673-8. doi: 10.1097/MCG.0b013e3181fbdfa6.

PMID:
21063208
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk